Lance Armstrong has decided against subjecting himself to an independent drug-testing programme because of cost and logistical problems.
The Texan, 37, competed for the first time in more than three years at last month's Tour Down Under, the first step in a comeback to raise awareness and funding for his global cancer foundation.
He had initially planned to hire anti-doping expert Don Catlin to supervise a transparent biological monitoring, over and above cycling's usual testing regime, as part of his return to the saddle.
However, Armstrong said on Wednesday through his lawyer he would instead use Ramsus Damsgaard, who runs his Astana team's internal testing programme.
"After a thorough review . . . the decision has been made to transfer the comprehensive programme we had planned to do with Don Catlin to Ramsus Damsgaard," Bill Stapleton, Armstrong's long-time agent and lawyer, said in a statement.
The Texan, 37, competed for the first time in more than three years at last month's Tour Down Under, the first step in a comeback to raise awareness and funding for his global cancer foundation.
He had initially planned to hire anti-doping expert Don Catlin to supervise a transparent biological monitoring, over and above cycling's usual testing regime, as part of his return to the saddle.
However, Armstrong said on Wednesday through his lawyer he would instead use Ramsus Damsgaard, who runs his Astana team's internal testing programme.
"After a thorough review . . . the decision has been made to transfer the comprehensive programme we had planned to do with Don Catlin to Ramsus Damsgaard," Bill Stapleton, Armstrong's long-time agent and lawyer, said in a statement.
Comment